ALS is a devastating, incurable disease that urgently needs innovative treatments and cell therapies have potential, but so far data on the most prominent candidate cellular drug, Nurown from BrainStorm Cell Therapeutics, have not convinced the FDA to approve it. The agency has wanted to see more data and hopefully more convincing data. Now an […]
The post ALS patients ask FDA to approve Nurown in tough test for Makary & Prasad appeared first on The Niche.